Innovating Amidst Austerity: Long-Term Strategies to Navigate 2024 and Beyond
The global pharmaceutical policy landscape has undergone seismic shifts in the last two years. Post-pandemic budgetary pressures, coupled with the need to generate revenue for other priorities, have compelled policymakers to tighten the financial screws on the industry.